Analysis of morbidity and mortality from cervical cancer in the Samara region for 10 years

Aim to study the dynamics of morbidity and mortality from cervical cancer, the age characteristics of the patients for the period 2010-2019 in the Samara region. Material and methods. We used the statistical data on morbidity and mortality in women with cervical cancer in the period from 2010 to 201...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Наука и инновации в медицине 2022-12, Vol.7 (4), p.258-263
Hauptverfasser: Okuneva, Irina V., Zolotareva, Tatyana G., Orlov, Andrei E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim to study the dynamics of morbidity and mortality from cervical cancer, the age characteristics of the patients for the period 2010-2019 in the Samara region. Material and methods. We used the statistical data on morbidity and mortality in women with cervical cancer in the period from 2010 to 2019, registered in the statistical reporting forms of the Samara region. Results. In 2010, 12,329 patients were diagnosed with malignant neoplasms (MN) for the first time, of which 281 patient (2.3%) was diagnosed with cervical cancer. In 2019, 14,456 patients were diagnosed with MN for the first time, of which 422 patients (3%) had cervical cancer. At the same time, the peak incidence of cervical cancer was registered in 2017 627 patients (4.5%). Between 2010 and 2019 there was an increase in patients with a confirmed diagnosis of cancer by 30.2%, and with a diagnosis of cervical cancer by 18.3%. Conclusion. The analysis indicates a trend towards an increase in the incidence of cervical cancer. This result may demonstrate both a real increase in the frequency of this pathology, where an unfavorable environmental situation in the Samara region may be a risk factor, and an improvement in the quality of diagnosis and statistical records.
ISSN:2500-1388
2618-754X
DOI:10.35693/2500-1388-2022-7-4-258-263